nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—SLC22A7—Fluorouracil—urinary bladder cancer	0.0749	0.127	CbGbCtD
Cimetidine—ABCB1—Mitomycin—urinary bladder cancer	0.0576	0.0975	CbGbCtD
Cimetidine—ABCB11—Doxorubicin—urinary bladder cancer	0.0471	0.0797	CbGbCtD
Cimetidine—SLC22A2—Cisplatin—urinary bladder cancer	0.0453	0.0766	CbGbCtD
Cimetidine—SLC22A11—Methotrexate—urinary bladder cancer	0.0433	0.0733	CbGbCtD
Cimetidine—SLC22A7—Methotrexate—urinary bladder cancer	0.0413	0.0698	CbGbCtD
Cimetidine—CYP3A4—Thiotepa—urinary bladder cancer	0.0262	0.0443	CbGbCtD
Cimetidine—SLC22A8—Methotrexate—urinary bladder cancer	0.0252	0.0426	CbGbCtD
Cimetidine—CYP2E1—Etoposide—urinary bladder cancer	0.0234	0.0396	CbGbCtD
Cimetidine—CYP2C8—Fluorouracil—urinary bladder cancer	0.021	0.0355	CbGbCtD
Cimetidine—CYP3A5—Etoposide—urinary bladder cancer	0.0182	0.0308	CbGbCtD
Cimetidine—SLC22A6—Methotrexate—urinary bladder cancer	0.0176	0.0297	CbGbCtD
Cimetidine—CYP2C8—Etoposide—urinary bladder cancer	0.0175	0.0296	CbGbCtD
Cimetidine—ABCB1—Gemcitabine—urinary bladder cancer	0.0166	0.0281	CbGbCtD
Cimetidine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0162	0.0274	CbGbCtD
Cimetidine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0146	0.0247	CbGbCtD
Cimetidine—CYP1A2—Etoposide—urinary bladder cancer	0.0135	0.0229	CbGbCtD
Cimetidine—CYP2C9—Cisplatin—urinary bladder cancer	0.0124	0.021	CbGbCtD
Cimetidine—ABCB1—Cisplatin—urinary bladder cancer	0.0121	0.0204	CbGbCtD
Cimetidine—ABCB1—Etoposide—urinary bladder cancer	0.0118	0.02	CbGbCtD
Cimetidine—ABCB1—Doxorubicin—urinary bladder cancer	0.00808	0.0137	CbGbCtD
Cimetidine—FMO3—urine—urinary bladder cancer	0.00799	0.0807	CbGeAlD
Cimetidine—ABCB1—Methotrexate—urinary bladder cancer	0.00782	0.0132	CbGbCtD
Cimetidine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00761	0.0129	CbGbCtD
Cimetidine—CYP3A4—Etoposide—urinary bladder cancer	0.00709	0.012	CbGbCtD
Cimetidine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00484	0.00818	CbGbCtD
Cimetidine—SLC22A8—urine—urinary bladder cancer	0.00421	0.0426	CbGeAlD
Cimetidine—CYP2C19—urine—urinary bladder cancer	0.00353	0.0357	CbGeAlD
Cimetidine—FMO1—prostate gland—urinary bladder cancer	0.00332	0.0335	CbGeAlD
Cimetidine—CYP1A2—urine—urinary bladder cancer	0.00288	0.0291	CbGeAlD
Cimetidine—FMO3—prostate gland—urinary bladder cancer	0.00287	0.029	CbGeAlD
Cimetidine—CYP2C9—urine—urinary bladder cancer	0.00274	0.0277	CbGeAlD
Cimetidine—CYP2E1—urine—urinary bladder cancer	0.00259	0.0262	CbGeAlD
Cimetidine—FMO1—renal system—urinary bladder cancer	0.00226	0.0229	CbGeAlD
Cimetidine—FMO1—urethra—urinary bladder cancer	0.00222	0.0225	CbGeAlD
Cimetidine—CYP3A4—urine—urinary bladder cancer	0.00209	0.0211	CbGeAlD
Cimetidine—CYP2D6—urine—urinary bladder cancer	0.00205	0.0208	CbGeAlD
Cimetidine—SLC47A1—prostate gland—urinary bladder cancer	0.00197	0.0199	CbGeAlD
Cimetidine—SLC22A11—renal system—urinary bladder cancer	0.00183	0.0185	CbGeAlD
Cimetidine—SLC22A7—renal system—urinary bladder cancer	0.00178	0.018	CbGeAlD
Cimetidine—SLC22A4—prostate gland—urinary bladder cancer	0.00173	0.0174	CbGeAlD
Cimetidine—SLC47A1—seminal vesicle—urinary bladder cancer	0.00167	0.0168	CbGeAlD
Cimetidine—FMO1—vagina—urinary bladder cancer	0.00164	0.0166	CbGeAlD
Cimetidine—SLC22A2—renal system—urinary bladder cancer	0.00159	0.016	CbGeAlD
Cimetidine—SLC22A3—prostate gland—urinary bladder cancer	0.00157	0.0159	CbGeAlD
Cimetidine—SLC22A8—prostate gland—urinary bladder cancer	0.00151	0.0153	CbGeAlD
Cimetidine—SLC22A11—female reproductive system—urinary bladder cancer	0.00146	0.0148	CbGeAlD
Cimetidine—SLC22A4—seminal vesicle—urinary bladder cancer	0.00146	0.0148	CbGeAlD
Cimetidine—FMO3—vagina—urinary bladder cancer	0.00142	0.0143	CbGeAlD
Cimetidine—SLC47A1—renal system—urinary bladder cancer	0.00134	0.0136	CbGeAlD
Cimetidine—SLC22A3—seminal vesicle—urinary bladder cancer	0.00133	0.0134	CbGeAlD
Cimetidine—SLC47A1—urethra—urinary bladder cancer	0.00132	0.0133	CbGeAlD
Cimetidine—SLC22A4—renal system—urinary bladder cancer	0.00118	0.0119	CbGeAlD
Cimetidine—SLC22A5—prostate gland—urinary bladder cancer	0.00114	0.0115	CbGeAlD
Cimetidine—SLC22A1—renal system—urinary bladder cancer	0.00112	0.0113	CbGeAlD
Cimetidine—SLC22A3—smooth muscle tissue—urinary bladder cancer	0.00111	0.0112	CbGeAlD
Cimetidine—SLC47A1—female reproductive system—urinary bladder cancer	0.00108	0.0109	CbGeAlD
Cimetidine—SLC22A3—renal system—urinary bladder cancer	0.00107	0.0108	CbGeAlD
Cimetidine—FMO1—lymph node—urinary bladder cancer	0.00106	0.0107	CbGeAlD
Cimetidine—SLC22A3—urethra—urinary bladder cancer	0.00105	0.0106	CbGeAlD
Cimetidine—SLC22A8—renal system—urinary bladder cancer	0.00103	0.0104	CbGeAlD
Cimetidine—CYP3A5—prostate gland—urinary bladder cancer	0.000999	0.0101	CbGeAlD
Cimetidine—SLC47A1—vagina—urinary bladder cancer	0.000973	0.00983	CbGeAlD
Cimetidine—SLC22A5—seminal vesicle—urinary bladder cancer	0.000967	0.00977	CbGeAlD
Cimetidine—SLC22A4—female reproductive system—urinary bladder cancer	0.000943	0.00952	CbGeAlD
Cimetidine—CYP2E1—prostate gland—urinary bladder cancer	0.000931	0.00941	CbGeAlD
Cimetidine—FMO3—lymph node—urinary bladder cancer	0.000916	0.00925	CbGeAlD
Cimetidine—SLC22A3—female reproductive system—urinary bladder cancer	0.000858	0.00867	CbGeAlD
Cimetidine—SLC22A4—vagina—urinary bladder cancer	0.000853	0.00861	CbGeAlD
Cimetidine—HRH2—lymph node—urinary bladder cancer	0.000815	0.00824	CbGeAlD
Cimetidine—SLC22A1—vagina—urinary bladder cancer	0.000812	0.0082	CbGeAlD
Cimetidine—CYP2E1—seminal vesicle—urinary bladder cancer	0.000788	0.00796	CbGeAlD
Cimetidine—SLC22A5—renal system—urinary bladder cancer	0.000779	0.00787	CbGeAlD
Cimetidine—SLC22A3—vagina—urinary bladder cancer	0.000776	0.00784	CbGeAlD
Cimetidine—SLC22A5—urethra—urinary bladder cancer	0.000765	0.00773	CbGeAlD
Cimetidine—CYP2C8—renal system—urinary bladder cancer	0.000754	0.00762	CbGeAlD
Cimetidine—CYP1A2—renal system—urinary bladder cancer	0.000706	0.00713	CbGeAlD
Cimetidine—CYP3A5—renal system—urinary bladder cancer	0.000681	0.00688	CbGeAlD
Cimetidine—CYP2E1—renal system—urinary bladder cancer	0.000635	0.00641	CbGeAlD
Cimetidine—SLC47A1—lymph node—urinary bladder cancer	0.000629	0.00636	CbGeAlD
Cimetidine—CYP2C19—vagina—urinary bladder cancer	0.000626	0.00632	CbGeAlD
Cimetidine—SLC22A5—female reproductive system—urinary bladder cancer	0.000624	0.0063	CbGeAlD
Cimetidine—CYP2E1—urethra—urinary bladder cancer	0.000624	0.0063	CbGeAlD
Cimetidine—CYP2C8—female reproductive system—urinary bladder cancer	0.000604	0.0061	CbGeAlD
Cimetidine—SLC22A5—vagina—urinary bladder cancer	0.000564	0.0057	CbGeAlD
Cimetidine—SLC22A4—lymph node—urinary bladder cancer	0.000552	0.00557	CbGeAlD
Cimetidine—CYP2C8—vagina—urinary bladder cancer	0.000546	0.00552	CbGeAlD
Cimetidine—CYP2C9—female reproductive system—urinary bladder cancer	0.000537	0.00542	CbGeAlD
Cimetidine—ABCB1—prostate gland—urinary bladder cancer	0.000531	0.00536	CbGeAlD
Cimetidine—Rash—Mitomycin—urinary bladder cancer	0.000529	0.00329	CcSEcCtD
Cimetidine—Dermatitis—Mitomycin—urinary bladder cancer	0.000529	0.00328	CcSEcCtD
Cimetidine—Headache—Mitomycin—urinary bladder cancer	0.000526	0.00327	CcSEcCtD
Cimetidine—Alopecia—Thiotepa—urinary bladder cancer	0.000525	0.00326	CcSEcCtD
Cimetidine—Liver injury—Doxorubicin—urinary bladder cancer	0.000524	0.00325	CcSEcCtD
Cimetidine—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00052	0.00323	CcSEcCtD
Cimetidine—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.000511	0.00317	CcSEcCtD
Cimetidine—CYP3A4—renal system—urinary bladder cancer	0.000511	0.00516	CbGeAlD
Cimetidine—Renal failure—Cisplatin—urinary bladder cancer	0.00051	0.00317	CcSEcCtD
Cimetidine—CYP2E1—female reproductive system—urinary bladder cancer	0.000508	0.00514	CbGeAlD
Cimetidine—Pancytopenia—Etoposide—urinary bladder cancer	0.000506	0.00314	CcSEcCtD
Cimetidine—CYP2D6—renal system—urinary bladder cancer	0.000503	0.00508	CbGeAlD
Cimetidine—SLC22A3—lymph node—urinary bladder cancer	0.000502	0.00507	CbGeAlD
Cimetidine—Neutropenia—Etoposide—urinary bladder cancer	0.000499	0.0031	CcSEcCtD
Cimetidine—Nausea—Mitomycin—urinary bladder cancer	0.000499	0.0031	CcSEcCtD
Cimetidine—CYP3A5—vagina—urinary bladder cancer	0.000493	0.00498	CbGeAlD
Cimetidine—Atrioventricular block—Epirubicin—urinary bladder cancer	0.000491	0.00305	CcSEcCtD
Cimetidine—Musculoskeletal pain—Epirubicin—urinary bladder cancer	0.000482	0.00299	CcSEcCtD
Cimetidine—Pneumonia—Etoposide—urinary bladder cancer	0.000478	0.00297	CcSEcCtD
Cimetidine—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.000478	0.00297	CcSEcCtD
Cimetidine—Agitation—Thiotepa—urinary bladder cancer	0.000475	0.00295	CcSEcCtD
Cimetidine—Bradycardia—Cisplatin—urinary bladder cancer	0.000474	0.00295	CcSEcCtD
Cimetidine—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000473	0.00293	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.000471	0.00293	CcSEcCtD
Cimetidine—Renal failure—Etoposide—urinary bladder cancer	0.000467	0.0029	CcSEcCtD
Cimetidine—Leukopenia—Thiotepa—urinary bladder cancer	0.000463	0.00287	CcSEcCtD
Cimetidine—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000456	0.00283	CcSEcCtD
Cimetidine—Atrioventricular block—Doxorubicin—urinary bladder cancer	0.000455	0.00282	CcSEcCtD
Cimetidine—ABCB1—seminal vesicle—urinary bladder cancer	0.000449	0.00453	CbGeAlD
Cimetidine—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.000447	0.00278	CcSEcCtD
Cimetidine—Musculoskeletal pain—Doxorubicin—urinary bladder cancer	0.000446	0.00277	CcSEcCtD
Cimetidine—Agranulocytosis—Etoposide—urinary bladder cancer	0.000444	0.00276	CcSEcCtD
Cimetidine—Alopecia—Gemcitabine—urinary bladder cancer	0.000442	0.00274	CcSEcCtD
Cimetidine—Myalgia—Thiotepa—urinary bladder cancer	0.00044	0.00273	CcSEcCtD
Cimetidine—Arthralgia—Thiotepa—urinary bladder cancer	0.00044	0.00273	CcSEcCtD
Cimetidine—Anxiety—Thiotepa—urinary bladder cancer	0.000439	0.00272	CcSEcCtD
Cimetidine—Alopecia—Fluorouracil—urinary bladder cancer	0.000434	0.0027	CcSEcCtD
Cimetidine—Confusional state—Thiotepa—urinary bladder cancer	0.000426	0.00264	CcSEcCtD
Cimetidine—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.000414	0.00257	CcSEcCtD
Cimetidine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000413	0.00257	CcSEcCtD
Cimetidine—Tachycardia—Thiotepa—urinary bladder cancer	0.000412	0.00256	CcSEcCtD
Cimetidine—Alopecia—Cisplatin—urinary bladder cancer	0.000412	0.00256	CcSEcCtD
Cimetidine—Hepatic failure—Methotrexate—urinary bladder cancer	0.000411	0.00255	CcSEcCtD
Cimetidine—CYP3A4—female reproductive system—urinary bladder cancer	0.000409	0.00413	CbGeAlD
Cimetidine—Erythema multiforme—Etoposide—urinary bladder cancer	0.000404	0.00251	CcSEcCtD
Cimetidine—CYP2D6—female reproductive system—urinary bladder cancer	0.000403	0.00407	CbGeAlD
Cimetidine—Flatulence—Cisplatin—urinary bladder cancer	0.0004	0.00248	CcSEcCtD
Cimetidine—Malaise—Gemcitabine—urinary bladder cancer	0.000392	0.00244	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.000392	0.00243	CcSEcCtD
Cimetidine—ABCB1—epithelium—urinary bladder cancer	0.00039	0.00394	CbGeAlD
Cimetidine—Leukopenia—Gemcitabine—urinary bladder cancer	0.00039	0.00242	CcSEcCtD
Cimetidine—Hepatic failure—Epirubicin—urinary bladder cancer	0.000385	0.00239	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000385	0.00239	CcSEcCtD
Cimetidine—Leukopenia—Fluorouracil—urinary bladder cancer	0.000383	0.00238	CcSEcCtD
Cimetidine—Alopecia—Etoposide—urinary bladder cancer	0.000377	0.00234	CcSEcCtD
Cimetidine—Somnolence—Thiotepa—urinary bladder cancer	0.000375	0.00233	CcSEcCtD
Cimetidine—Myalgia—Gemcitabine—urinary bladder cancer	0.00037	0.0023	CcSEcCtD
Cimetidine—Arthralgia—Gemcitabine—urinary bladder cancer	0.00037	0.0023	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000367	0.00228	CcSEcCtD
Cimetidine—Malaise—Cisplatin—urinary bladder cancer	0.000366	0.00227	CcSEcCtD
Cimetidine—SLC22A5—lymph node—urinary bladder cancer	0.000365	0.00369	CbGeAlD
Cimetidine—Myalgia—Fluorouracil—urinary bladder cancer	0.000364	0.00226	CcSEcCtD
Cimetidine—Fatigue—Thiotepa—urinary bladder cancer	0.000364	0.00226	CcSEcCtD
Cimetidine—Renal impairment—Epirubicin—urinary bladder cancer	0.000363	0.00226	CcSEcCtD
Cimetidine—Leukopenia—Cisplatin—urinary bladder cancer	0.000363	0.00225	CcSEcCtD
Cimetidine—ABCB1—renal system—urinary bladder cancer	0.000362	0.00365	CbGeAlD
Cimetidine—Constipation—Thiotepa—urinary bladder cancer	0.000361	0.00224	CcSEcCtD
Cimetidine—Hepatic failure—Doxorubicin—urinary bladder cancer	0.000356	0.00221	CcSEcCtD
Cimetidine—ABCB1—urethra—urinary bladder cancer	0.000355	0.00359	CbGeAlD
Cimetidine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000355	0.00221	CcSEcCtD
Cimetidine—Confusional state—Fluorouracil—urinary bladder cancer	0.000352	0.00219	CcSEcCtD
Cimetidine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000349	0.00217	CcSEcCtD
Cimetidine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000348	0.00216	CcSEcCtD
Cimetidine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000348	0.00216	CcSEcCtD
Cimetidine—Myalgia—Cisplatin—urinary bladder cancer	0.000345	0.00214	CcSEcCtD
Cimetidine—Anxiety—Cisplatin—urinary bladder cancer	0.000344	0.00214	CcSEcCtD
Cimetidine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000342	0.00212	CcSEcCtD
Cimetidine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000341	0.00212	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000339	0.00211	CcSEcCtD
Cimetidine—Renal impairment—Doxorubicin—urinary bladder cancer	0.000336	0.00209	CcSEcCtD
Cimetidine—Malaise—Etoposide—urinary bladder cancer	0.000335	0.00208	CcSEcCtD
Cimetidine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000334	0.00207	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000333	0.00207	CcSEcCtD
Cimetidine—Leukopenia—Etoposide—urinary bladder cancer	0.000333	0.00207	CcSEcCtD
Cimetidine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000331	0.00206	CcSEcCtD
Cimetidine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000324	0.00201	CcSEcCtD
Cimetidine—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000324	0.00201	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000324	0.00201	CcSEcCtD
Cimetidine—Tachycardia—Cisplatin—urinary bladder cancer	0.000323	0.00201	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000318	0.00198	CcSEcCtD
Cimetidine—Somnolence—Gemcitabine—urinary bladder cancer	0.000316	0.00196	CcSEcCtD
Cimetidine—Pancreatitis—Methotrexate—urinary bladder cancer	0.000313	0.00194	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000311	0.00193	CcSEcCtD
Cimetidine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000311	0.00193	CcSEcCtD
Cimetidine—Somnolence—Fluorouracil—urinary bladder cancer	0.00031	0.00193	CcSEcCtD
Cimetidine—Fatigue—Gemcitabine—urinary bladder cancer	0.000306	0.0019	CcSEcCtD
Cimetidine—Confusional state—Etoposide—urinary bladder cancer	0.000306	0.0019	CcSEcCtD
Cimetidine—Constipation—Gemcitabine—urinary bladder cancer	0.000304	0.00189	CcSEcCtD
Cimetidine—Pancytopenia—Methotrexate—urinary bladder cancer	0.000303	0.00188	CcSEcCtD
Cimetidine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000303	0.00188	CcSEcCtD
Cimetidine—Asthenia—Thiotepa—urinary bladder cancer	0.000303	0.00188	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000302	0.00187	CcSEcCtD
Cimetidine—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.0003	0.00186	CcSEcCtD
Cimetidine—Neutropenia—Methotrexate—urinary bladder cancer	0.000299	0.00185	CcSEcCtD
Cimetidine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000297	0.00184	CcSEcCtD
Cimetidine—Tachycardia—Etoposide—urinary bladder cancer	0.000296	0.00184	CcSEcCtD
Cimetidine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000294	0.00183	CcSEcCtD
Cimetidine—Pancreatitis—Epirubicin—urinary bladder cancer	0.000293	0.00182	CcSEcCtD
Cimetidine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000293	0.00182	CcSEcCtD
Cimetidine—ABCB1—female reproductive system—urinary bladder cancer	0.00029	0.00293	CbGeAlD
Cimetidine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000289	0.00179	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000288	0.00179	CcSEcCtD
Cimetidine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000288	0.00179	CcSEcCtD
Cimetidine—Pneumonia—Methotrexate—urinary bladder cancer	0.000286	0.00178	CcSEcCtD
Cimetidine—Drowsiness—Methotrexate—urinary bladder cancer	0.000285	0.00177	CcSEcCtD
Cimetidine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000284	0.00176	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000282	0.00175	CcSEcCtD
Cimetidine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000281	0.00174	CcSEcCtD
Cimetidine—Renal failure—Methotrexate—urinary bladder cancer	0.00028	0.00174	CcSEcCtD
Cimetidine—Neutropenia—Epirubicin—urinary bladder cancer	0.00028	0.00174	CcSEcCtD
Cimetidine—Dizziness—Thiotepa—urinary bladder cancer	0.000279	0.00173	CcSEcCtD
Cimetidine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000276	0.00171	CcSEcCtD
Cimetidine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000273	0.00169	CcSEcCtD
Cimetidine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000271	0.00168	CcSEcCtD
Cimetidine—Somnolence—Etoposide—urinary bladder cancer	0.00027	0.00167	CcSEcCtD
Cimetidine—Vomiting—Thiotepa—urinary bladder cancer	0.000268	0.00167	CcSEcCtD
Cimetidine—Pneumonia—Epirubicin—urinary bladder cancer	0.000268	0.00166	CcSEcCtD
Cimetidine—Drowsiness—Epirubicin—urinary bladder cancer	0.000267	0.00165	CcSEcCtD
Cimetidine—Rash—Thiotepa—urinary bladder cancer	0.000266	0.00165	CcSEcCtD
Cimetidine—Dermatitis—Thiotepa—urinary bladder cancer	0.000266	0.00165	CcSEcCtD
Cimetidine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000266	0.00165	CcSEcCtD
Cimetidine—Headache—Thiotepa—urinary bladder cancer	0.000264	0.00164	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000264	0.00164	CcSEcCtD
Cimetidine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000263	0.00163	CcSEcCtD
Cimetidine—Renal failure—Epirubicin—urinary bladder cancer	0.000262	0.00163	CcSEcCtD
Cimetidine—ABCB1—vagina—urinary bladder cancer	0.000262	0.00265	CbGeAlD
Cimetidine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000262	0.00162	CcSEcCtD
Cimetidine—Fatigue—Etoposide—urinary bladder cancer	0.000261	0.00162	CcSEcCtD
Cimetidine—Constipation—Etoposide—urinary bladder cancer	0.000259	0.00161	CcSEcCtD
Cimetidine—Neutropenia—Doxorubicin—urinary bladder cancer	0.000259	0.00161	CcSEcCtD
Cimetidine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000257	0.0016	CcSEcCtD
Cimetidine—Hepatitis—Methotrexate—urinary bladder cancer	0.000256	0.00159	CcSEcCtD
Cimetidine—Asthenia—Gemcitabine—urinary bladder cancer	0.000255	0.00158	CcSEcCtD
Cimetidine—Nausea—Thiotepa—urinary bladder cancer	0.000251	0.00156	CcSEcCtD
Cimetidine—Feeling abnormal—Etoposide—urinary bladder cancer	0.00025	0.00155	CcSEcCtD
Cimetidine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000249	0.00154	CcSEcCtD
Cimetidine—Pneumonia—Doxorubicin—urinary bladder cancer	0.000248	0.00154	CcSEcCtD
Cimetidine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000247	0.00153	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000245	0.00152	CcSEcCtD
Cimetidine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000244	0.00151	CcSEcCtD
Cimetidine—Bradycardia—Epirubicin—urinary bladder cancer	0.000244	0.00151	CcSEcCtD
Cimetidine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000243	0.00151	CcSEcCtD
Cimetidine—Renal failure—Doxorubicin—urinary bladder cancer	0.000242	0.00151	CcSEcCtD
Cimetidine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000242	0.0015	CcSEcCtD
Cimetidine—Body temperature increased—Etoposide—urinary bladder cancer	0.00024	0.00149	CcSEcCtD
Cimetidine—Hepatitis—Epirubicin—urinary bladder cancer	0.000239	0.00149	CcSEcCtD
Cimetidine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000239	0.00148	CcSEcCtD
Cimetidine—Asthenia—Cisplatin—urinary bladder cancer	0.000238	0.00147	CcSEcCtD
Cimetidine—Dizziness—Fluorouracil—urinary bladder cancer	0.000231	0.00143	CcSEcCtD
Cimetidine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00023	0.00143	CcSEcCtD
Cimetidine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000226	0.00141	CcSEcCtD
Cimetidine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000226	0.0014	CcSEcCtD
Cimetidine—Alopecia—Methotrexate—urinary bladder cancer	0.000226	0.0014	CcSEcCtD
Cimetidine—Vomiting—Gemcitabine—urinary bladder cancer	0.000226	0.0014	CcSEcCtD
Cimetidine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000225	0.0014	CcSEcCtD
Cimetidine—Rash—Gemcitabine—urinary bladder cancer	0.000224	0.00139	CcSEcCtD
Cimetidine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000224	0.00139	CcSEcCtD
Cimetidine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000223	0.00139	CcSEcCtD
Cimetidine—Headache—Gemcitabine—urinary bladder cancer	0.000222	0.00138	CcSEcCtD
Cimetidine—Vomiting—Fluorouracil—urinary bladder cancer	0.000222	0.00138	CcSEcCtD
Cimetidine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000221	0.00137	CcSEcCtD
Cimetidine—Rash—Fluorouracil—urinary bladder cancer	0.00022	0.00137	CcSEcCtD
Cimetidine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00022	0.00137	CcSEcCtD
Cimetidine—Headache—Fluorouracil—urinary bladder cancer	0.000219	0.00136	CcSEcCtD
Cimetidine—Asthenia—Etoposide—urinary bladder cancer	0.000218	0.00135	CcSEcCtD
Cimetidine—Alopecia—Epirubicin—urinary bladder cancer	0.000211	0.00131	CcSEcCtD
Cimetidine—Nausea—Gemcitabine—urinary bladder cancer	0.000211	0.00131	CcSEcCtD
Cimetidine—Vomiting—Cisplatin—urinary bladder cancer	0.00021	0.00131	CcSEcCtD
Cimetidine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000209	0.0013	CcSEcCtD
Cimetidine—Rash—Cisplatin—urinary bladder cancer	0.000209	0.0013	CcSEcCtD
Cimetidine—Dermatitis—Cisplatin—urinary bladder cancer	0.000209	0.00129	CcSEcCtD
Cimetidine—Diarrhoea—Etoposide—urinary bladder cancer	0.000208	0.00129	CcSEcCtD
Cimetidine—Nausea—Fluorouracil—urinary bladder cancer	0.000207	0.00129	CcSEcCtD
Cimetidine—Flatulence—Epirubicin—urinary bladder cancer	0.000205	0.00127	CcSEcCtD
Cimetidine—Malaise—Methotrexate—urinary bladder cancer	0.000201	0.00125	CcSEcCtD
Cimetidine—Dizziness—Etoposide—urinary bladder cancer	0.000201	0.00125	CcSEcCtD
Cimetidine—Leukopenia—Methotrexate—urinary bladder cancer	0.000199	0.00124	CcSEcCtD
Cimetidine—Nausea—Cisplatin—urinary bladder cancer	0.000197	0.00122	CcSEcCtD
Cimetidine—Alopecia—Doxorubicin—urinary bladder cancer	0.000196	0.00121	CcSEcCtD
Cimetidine—Vomiting—Etoposide—urinary bladder cancer	0.000193	0.0012	CcSEcCtD
Cimetidine—Agitation—Epirubicin—urinary bladder cancer	0.000191	0.00119	CcSEcCtD
Cimetidine—Rash—Etoposide—urinary bladder cancer	0.000191	0.00119	CcSEcCtD
Cimetidine—Dermatitis—Etoposide—urinary bladder cancer	0.000191	0.00119	CcSEcCtD
Cimetidine—Headache—Etoposide—urinary bladder cancer	0.00019	0.00118	CcSEcCtD
Cimetidine—Flatulence—Doxorubicin—urinary bladder cancer	0.00019	0.00118	CcSEcCtD
Cimetidine—Arthralgia—Methotrexate—urinary bladder cancer	0.000189	0.00118	CcSEcCtD
Cimetidine—Myalgia—Methotrexate—urinary bladder cancer	0.000189	0.00118	CcSEcCtD
Cimetidine—Malaise—Epirubicin—urinary bladder cancer	0.000188	0.00117	CcSEcCtD
Cimetidine—Leukopenia—Epirubicin—urinary bladder cancer	0.000186	0.00116	CcSEcCtD
Cimetidine—Confusional state—Methotrexate—urinary bladder cancer	0.000183	0.00114	CcSEcCtD
Cimetidine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000182	0.00113	CcSEcCtD
Cimetidine—Nausea—Etoposide—urinary bladder cancer	0.00018	0.00112	CcSEcCtD
Cimetidine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000178	0.0011	CcSEcCtD
Cimetidine—Arthralgia—Epirubicin—urinary bladder cancer	0.000177	0.0011	CcSEcCtD
Cimetidine—Myalgia—Epirubicin—urinary bladder cancer	0.000177	0.0011	CcSEcCtD
Cimetidine—Agitation—Doxorubicin—urinary bladder cancer	0.000177	0.0011	CcSEcCtD
Cimetidine—Anxiety—Epirubicin—urinary bladder cancer	0.000177	0.0011	CcSEcCtD
Cimetidine—Malaise—Doxorubicin—urinary bladder cancer	0.000174	0.00108	CcSEcCtD
Cimetidine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000173	0.00107	CcSEcCtD
Cimetidine—Confusional state—Epirubicin—urinary bladder cancer	0.000171	0.00106	CcSEcCtD
Cimetidine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00017	0.00106	CcSEcCtD
Cimetidine—ABCB1—lymph node—urinary bladder cancer	0.000169	0.00171	CbGeAlD
Cimetidine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000166	0.00103	CcSEcCtD
Cimetidine—Tachycardia—Epirubicin—urinary bladder cancer	0.000166	0.00103	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000166	0.00103	CcSEcCtD
Cimetidine—Myalgia—Doxorubicin—urinary bladder cancer	0.000164	0.00102	CcSEcCtD
Cimetidine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000164	0.00102	CcSEcCtD
Cimetidine—Anxiety—Doxorubicin—urinary bladder cancer	0.000164	0.00102	CcSEcCtD
Cimetidine—Somnolence—Methotrexate—urinary bladder cancer	0.000161	0.001	CcSEcCtD
Cimetidine—Confusional state—Doxorubicin—urinary bladder cancer	0.000159	0.000985	CcSEcCtD
Cimetidine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000157	0.000977	CcSEcCtD
Cimetidine—Fatigue—Methotrexate—urinary bladder cancer	0.000157	0.000972	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000155	0.000962	CcSEcCtD
Cimetidine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000154	0.000956	CcSEcCtD
Cimetidine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000154	0.000953	CcSEcCtD
Cimetidine—Somnolence—Epirubicin—urinary bladder cancer	0.000151	0.000938	CcSEcCtD
Cimetidine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00015	0.000929	CcSEcCtD
Cimetidine—Fatigue—Epirubicin—urinary bladder cancer	0.000147	0.00091	CcSEcCtD
Cimetidine—Constipation—Epirubicin—urinary bladder cancer	0.000145	0.000903	CcSEcCtD
Cimetidine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000144	0.000892	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000143	0.00089	CcSEcCtD
Cimetidine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00014	0.00087	CcSEcCtD
Cimetidine—Somnolence—Doxorubicin—urinary bladder cancer	0.00014	0.000868	CcSEcCtD
Cimetidine—Fatigue—Doxorubicin—urinary bladder cancer	0.000136	0.000842	CcSEcCtD
Cimetidine—Constipation—Doxorubicin—urinary bladder cancer	0.000135	0.000835	CcSEcCtD
Cimetidine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000134	0.000834	CcSEcCtD
Cimetidine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000134	0.000831	CcSEcCtD
Cimetidine—Asthenia—Methotrexate—urinary bladder cancer	0.00013	0.000809	CcSEcCtD
Cimetidine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00013	0.000805	CcSEcCtD
Cimetidine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000125	0.000778	CcSEcCtD
Cimetidine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000124	0.000772	CcSEcCtD
Cimetidine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000124	0.000772	CcSEcCtD
Cimetidine—Asthenia—Epirubicin—urinary bladder cancer	0.000122	0.000757	CcSEcCtD
Cimetidine—Dizziness—Methotrexate—urinary bladder cancer	0.00012	0.000746	CcSEcCtD
Cimetidine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000116	0.000722	CcSEcCtD
Cimetidine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000116	0.00072	CcSEcCtD
Cimetidine—Vomiting—Methotrexate—urinary bladder cancer	0.000115	0.000717	CcSEcCtD
Cimetidine—Rash—Methotrexate—urinary bladder cancer	0.000115	0.000711	CcSEcCtD
Cimetidine—Dermatitis—Methotrexate—urinary bladder cancer	0.000114	0.00071	CcSEcCtD
Cimetidine—Headache—Methotrexate—urinary bladder cancer	0.000114	0.000707	CcSEcCtD
Cimetidine—Asthenia—Doxorubicin—urinary bladder cancer	0.000113	0.000701	CcSEcCtD
Cimetidine—Dizziness—Epirubicin—urinary bladder cancer	0.000112	0.000698	CcSEcCtD
Cimetidine—Vomiting—Epirubicin—urinary bladder cancer	0.000108	0.000671	CcSEcCtD
Cimetidine—Nausea—Methotrexate—urinary bladder cancer	0.000108	0.00067	CcSEcCtD
Cimetidine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000108	0.000668	CcSEcCtD
Cimetidine—Rash—Epirubicin—urinary bladder cancer	0.000107	0.000665	CcSEcCtD
Cimetidine—Dermatitis—Epirubicin—urinary bladder cancer	0.000107	0.000665	CcSEcCtD
Cimetidine—Headache—Epirubicin—urinary bladder cancer	0.000106	0.000661	CcSEcCtD
Cimetidine—Dizziness—Doxorubicin—urinary bladder cancer	0.000104	0.000646	CcSEcCtD
Cimetidine—Nausea—Epirubicin—urinary bladder cancer	0.000101	0.000627	CcSEcCtD
Cimetidine—Vomiting—Doxorubicin—urinary bladder cancer	0.0001	0.000621	CcSEcCtD
Cimetidine—Rash—Doxorubicin—urinary bladder cancer	9.92e-05	0.000616	CcSEcCtD
Cimetidine—Dermatitis—Doxorubicin—urinary bladder cancer	9.91e-05	0.000615	CcSEcCtD
Cimetidine—Headache—Doxorubicin—urinary bladder cancer	9.85e-05	0.000612	CcSEcCtD
Cimetidine—Nausea—Doxorubicin—urinary bladder cancer	9.34e-05	0.00058	CcSEcCtD
Cimetidine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.57e-05	0.000105	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.55e-05	0.000104	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.53e-05	0.000103	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.53e-05	0.000103	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—CREBBP—urinary bladder cancer	1.52e-05	0.000102	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.52e-05	0.000102	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.52e-05	0.000102	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PPARG—urinary bladder cancer	1.52e-05	0.000102	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.51e-05	0.000101	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	1.51e-05	0.000101	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—CREBBP—urinary bladder cancer	1.46e-05	9.79e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.44e-05	9.7e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.43e-05	9.61e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.42e-05	9.53e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CREBBP—urinary bladder cancer	1.41e-05	9.48e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.4e-05	9.44e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.4e-05	9.44e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	1.4e-05	9.43e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.4e-05	9.42e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—TYMS—urinary bladder cancer	1.4e-05	9.41e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.4e-05	9.39e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IGF1—urinary bladder cancer	1.39e-05	9.36e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.39e-05	9.32e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.39e-05	9.32e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—EGFR—urinary bladder cancer	1.39e-05	9.32e-05	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PTEN—urinary bladder cancer	1.38e-05	9.31e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	1.38e-05	9.3e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	1.38e-05	9.3e-05	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.36e-05	9.17e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.36e-05	9.16e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.35e-05	9.11e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.35e-05	9.1e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.35e-05	9.08e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.34e-05	9.02e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.34e-05	9e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.33e-05	8.92e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—GPX1—urinary bladder cancer	1.32e-05	8.91e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.32e-05	8.88e-05	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—EP300—urinary bladder cancer	1.32e-05	8.88e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.31e-05	8.8e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—KRAS—urinary bladder cancer	1.31e-05	8.8e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.31e-05	8.79e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—TYMS—urinary bladder cancer	1.3e-05	8.77e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.3e-05	8.77e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.3e-05	8.76e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	1.3e-05	8.75e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.3e-05	8.72e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	1.29e-05	8.67e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	1.29e-05	8.67e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—RHOA—urinary bladder cancer	1.28e-05	8.58e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.25e-05	8.43e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.25e-05	8.43e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.25e-05	8.38e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.24e-05	8.37e-05	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PTGS2—urinary bladder cancer	1.24e-05	8.36e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—GPX1—urinary bladder cancer	1.23e-05	8.3e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.23e-05	8.3e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.22e-05	8.23e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.22e-05	8.23e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.22e-05	8.23e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	1.22e-05	8.22e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.22e-05	8.21e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.22e-05	8.17e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	1.21e-05	8.15e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.2e-05	8.05e-05	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PTGS2—urinary bladder cancer	1.19e-05	8.02e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.19e-05	7.98e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—ERBB2—urinary bladder cancer	1.18e-05	7.94e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.15e-05	7.75e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.15e-05	7.75e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.14e-05	7.68e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.14e-05	7.68e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	1.14e-05	7.66e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.14e-05	7.64e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.13e-05	7.61e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CXCL8—urinary bladder cancer	1.12e-05	7.53e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.12e-05	7.52e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—HRAS—urinary bladder cancer	1.11e-05	7.48e-05	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.11e-05	7.47e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.11e-05	7.45e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.1e-05	7.38e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	1.09e-05	7.34e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.09e-05	7.34e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.09e-05	7.33e-05	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PTEN—urinary bladder cancer	1.08e-05	7.29e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL2—urinary bladder cancer	1.07e-05	7.2e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.05e-05	7.09e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CCND1—urinary bladder cancer	1.04e-05	7.01e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.04e-05	7.01e-05	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PTEN—urinary bladder cancer	1.04e-05	6.99e-05	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—EP300—urinary bladder cancer	1.03e-05	6.95e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	1.02e-05	6.83e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.01e-05	6.81e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MMP9—urinary bladder cancer	1.01e-05	6.81e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.01e-05	6.79e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CDKN1A—urinary bladder cancer	1.01e-05	6.79e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PTEN—urinary bladder cancer	1.01e-05	6.77e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	1e-05	6.75e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	1e-05	6.75e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1e-05	6.73e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1e-05	6.73e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	9.93e-06	6.68e-05	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—EP300—urinary bladder cancer	9.92e-06	6.67e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PPARG—urinary bladder cancer	9.91e-06	6.67e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—NQO1—urinary bladder cancer	9.86e-06	6.63e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.8e-06	6.59e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	9.77e-06	6.57e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	9.77e-06	6.57e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.71e-06	6.53e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	9.61e-06	6.46e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—EP300—urinary bladder cancer	9.6e-06	6.46e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	9.59e-06	6.45e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.58e-06	6.44e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	9.54e-06	6.41e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	9.52e-06	6.4e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	9.47e-06	6.37e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	9.44e-06	6.35e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	9.44e-06	6.34e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	9.43e-06	6.34e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	9.42e-06	6.33e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—SRC—urinary bladder cancer	9.34e-06	6.28e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.33e-06	6.27e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	9.29e-06	6.25e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PPARG—urinary bladder cancer	9.24e-06	6.21e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	9.21e-06	6.19e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.13e-06	6.14e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.94e-06	6.01e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	8.88e-06	5.97e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	8.87e-06	5.96e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	8.85e-06	5.95e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	8.78e-06	5.9e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	8.68e-06	5.83e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	8.68e-06	5.83e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.55e-06	5.75e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	8.43e-06	5.67e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MYC—urinary bladder cancer	8.37e-06	5.63e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	8.31e-06	5.59e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	8.22e-06	5.53e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—EGFR—urinary bladder cancer	8.19e-06	5.5e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	8.16e-06	5.48e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.15e-06	5.48e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	8.14e-06	5.47e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	7.87e-06	5.29e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	7.83e-06	5.27e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	7.81e-06	5.25e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	7.8e-06	5.24e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.79e-06	5.24e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	7.75e-06	5.21e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	7.74e-06	5.21e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	7.74e-06	5.21e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—KRAS—urinary bladder cancer	7.73e-06	5.2e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	7.68e-06	5.17e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	7.67e-06	5.15e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—TYMS—urinary bladder cancer	7.65e-06	5.14e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.64e-06	5.14e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	7.56e-06	5.08e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	7.56e-06	5.08e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	7.54e-06	5.07e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	7.54e-06	5.07e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.43e-06	5e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	7.42e-06	4.99e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	7.31e-06	4.92e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	7.28e-06	4.89e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	7.27e-06	4.89e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GPX1—urinary bladder cancer	7.24e-06	4.87e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	7.21e-06	4.84e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	7.19e-06	4.84e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	7.18e-06	4.83e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	7.14e-06	4.8e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	7.12e-06	4.79e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	7.12e-06	4.79e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	7.11e-06	4.78e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	7.06e-06	4.75e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	7.06e-06	4.75e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	6.91e-06	4.65e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	6.9e-06	4.64e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TP53—urinary bladder cancer	6.87e-06	4.62e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	6.84e-06	4.6e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	6.82e-06	4.59e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	6.81e-06	4.58e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PTEN—urinary bladder cancer	6.8e-06	4.57e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	6.76e-06	4.55e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	6.7e-06	4.5e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	6.68e-06	4.49e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.66e-06	4.48e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	6.64e-06	4.46e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—HRAS—urinary bladder cancer	6.57e-06	4.42e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	6.57e-06	4.41e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—EP300—urinary bladder cancer	6.5e-06	4.37e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—EP300—urinary bladder cancer	6.49e-06	4.36e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.35e-06	4.27e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PTEN—urinary bladder cancer	6.34e-06	4.26e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	6.29e-06	4.23e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	6.24e-06	4.2e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	6.22e-06	4.18e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	6.1e-06	4.1e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.08e-06	4.08e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—EP300—urinary bladder cancer	6.05e-06	4.06e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	6.03e-06	4.06e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	6.03e-06	4.06e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	5.97e-06	4.02e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	5.78e-06	3.88e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	5.67e-06	3.81e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	5.66e-06	3.8e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	5.65e-06	3.8e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	5.55e-06	3.73e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.42e-06	3.64e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	5.33e-06	3.59e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	5.33e-06	3.58e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	5.2e-06	3.5e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	5.1e-06	3.43e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.07e-06	3.41e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	5.06e-06	3.4e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	4.93e-06	3.32e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	4.92e-06	3.31e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	4.9e-06	3.3e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	4.89e-06	3.29e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	4.86e-06	3.27e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.71e-06	3.17e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—EP300—urinary bladder cancer	4.71e-06	3.16e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—EP300—urinary bladder cancer	4.7e-06	3.16e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.66e-06	3.13e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.66e-06	3.13e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.46e-06	3e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.38e-06	2.94e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	4.37e-06	2.94e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	4.32e-06	2.91e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	4.27e-06	2.87e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.26e-06	2.86e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	4.15e-06	2.79e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.12e-06	2.77e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—EP300—urinary bladder cancer	4.07e-06	2.73e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	4.02e-06	2.7e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.98e-06	2.68e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	3.81e-06	2.56e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.72e-06	2.5e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—EP300—urinary bladder cancer	3.63e-06	2.44e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—EP300—urinary bladder cancer	3.54e-06	2.38e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.5e-06	2.35e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.47e-06	2.33e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.4e-06	2.29e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.34e-06	2.25e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.34e-06	2.24e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—EP300—urinary bladder cancer	3.31e-06	2.23e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.21e-06	2.16e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	2.97e-06	1.99e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—EP300—urinary bladder cancer	2.83e-06	1.9e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.63e-06	1.76e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.29e-06	1.54e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.18e-06	1.47e-05	CbGpPWpGaD
